DISCLAIMER
The information and materials accessed through or made available for use on any of our Sites, including, any information about diseases, conditions, treatments, or medicines, are for informational purposes only. The Content is not intended to be and is not a substitute for professional medical advice, diagnosis, or treatment, and your participation on our Sites does not create a healthcare professional-patient relationship. You should consult a doctor or other qualified health care professional regarding any questions you have about your health or before making any decisions related to your health or wellness. Call your doctor or 911 immediately if you think you may have a medical emergency.message sent
email sent successfully
You are receiving this because you have an account on www.oneGRAVESvoice.com | ||
To unsubscribe from these emails, click here |
Trusted Resources: Community Center
Online groups, photo galleries and blogs
Management of Thyroid Eye Disease – Dr. Don Kikkawa
In this interview from AAO 2018, Dr. Don Kikkawa discusses management strategies for thyroid eye disease (TED). He explains that differentiating of the type of disease — self-limiting versus aggressive — is critical in determining the treatment course. Dr. Kikkawa also presents an overview of available therapies for TED.

Related Content
-
News & MeetingsGraves’ and Thyroid Eye Disease Support Group MeetingThis event is hosted by Graves' Dise...
-
People & PlacesScheie Eye Institute – Thyroid Eye Disease ProgramScheie’s Thyroid Eye Disease Program o...
-
News & MeetingsGut Microbes May Play Role in Graves ’ Disease Diagnosis, Thyroid AutoimmunityThe abundance and diversity of intestina...
-
People & PlacesEdinburgh Centre for Endocrinology and Diabetes – Thyroid Eye ClinicThe Thyroid Eye Clinic is a regional ref...
-
Evidence & EducationEfficacy of Orbital Radiotherapy in Moderate-to-Severe Active Graves’ Orbitopathy Including Long-Lasting Disease: ...Background: We aimed to explore the eff...
-
News & MeetingsClinical Study Data Highlighting the Impact of Teprotumumab in Patients With Active Thyroid Eye Disease to Be Presen...Horizon Therapeutics plc today announced...
-
Evidence & EducationGraves’ Orbitopathy: Reevaluating Rundle’s CurveGraves’ orbitopathy (GO) is the most c...
send a message
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.